EvoPAR-PR01

Von Elena Bentley / 1. Juli 2024

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents (EvoPAR-PR01; NCT06120491)